Please login to the form below
rolapitant
This page shows the latest rolapitant news and features for those working in and with pharma, biotech and healthcare.
Tesaro joins PARP parade with US approval of Zejula
The approval comes at a buoyant time for Tesaro, which is still rolling out its first commercial product in the US - the chemotherapy-induced nausea and vomiting drug Varubi (rolapitant) - and
Latest news
-
J&J gets CHMP backing for broader Darzalex use
Tesaro picked up a positive opinion for Varuby (rolapitant), an oral substance P/neurokinin-1 (NK-1) receptor antagonist for treating chemotherapy-induced nausea and vomiting, and Shire got the
-
Rare disease therapies head the ‘class of 2015’
Relypsa. USA. rolapitant. Varubi. chemotherapy-induced nausea and vomiting (CINV). neurokinin-1 receptor antagonist.
-
Merck plans expanded filing for Emend this year
Generics aside, competition is building in the CINV sector. Last October the FDA approved Eisai's combination Akynzeo (netupitant and palonosterol), while Tesaro's oral and injectable NK1 antagonist rolapitant was
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn
- Landscape review reveals £1.1bn of UK funding for rare diseases
- Cancer Research UK partners with French cancer institute
- New diagnosis pathway has been launched to mark European Myeloma Day
- Impacting Lives with Rare Disease Education
- Sandoz biosimilar receives EC approval to treat MS
No results were found
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
